1.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

2.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

3.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

4.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

5.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

6.

Additional file 1 of Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series

1.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

2.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

3.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

4.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

5.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

6.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

7.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

8.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

9.

Distribution of the number of colistin-resistant Enterobacterales species by One Health sector and country.

1.

S2 Fig -

2.

S2 Fig -

3.

S2 Fig -

4.

S2 Fig -

5.

S2 Fig -

6.

S2 Fig -

7.

S2 Fig -

8.

S2 Fig -

9.

S2 Fig -

1.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

2.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

3.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

4.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

5.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

6.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

7.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

8.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

9.

Global view of BLAST comparisons between the mcr -harboring sequences and the most similar reference plasmid sequence (in grey) according to blastn.

1.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

2.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

3.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

4.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

5.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

6.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

7.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

8.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

9.

Virulence potential of ColR-E from different One Health sectors in Belgium and the Netherlands.

1.

Percentages of SAM meeting the eligibility criteria (weighted data).

2.

Percentages of SAM meeting the eligibility criteria (weighted data).

3.

Percentages of SAM meeting the eligibility criteria (weighted data).

1.

Eligibility criteria associated to sociodemographic, economic, migration related factors and forced sex.

2.

Eligibility criteria associated to sociodemographic, economic, migration related factors and forced sex.

3.

Eligibility criteria associated to sociodemographic, economic, migration related factors and forced sex.

1.

Interpretation of the results of the logistic regression analyses for the separate eligibility criteria.

2.

Interpretation of the results of the logistic regression analyses for the separate eligibility criteria.

3.

Interpretation of the results of the logistic regression analyses for the separate eligibility criteria.

1.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

2.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

3.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

4.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

5.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

6.

Additional file 1 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

1.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

2.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

3.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

4.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

5.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020

6.

Additional file 2 of COVID-19 cases, hospitalizations and deaths in Belgian nursing homes: results of a surveillance conducted between April and December 2020